PROVIDER PROFILE · NPI 1316984800

Sudha KarupaiahMD

PRACTICESUDHA KARUPAIAH MD PCSee all providers at this practice →

Sleep MedicineSan Jose, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

613

Unique beneficiaries

—

Total services

1,190

Distinct HCPCS

Medicare payment

$190K

Peer benchmark

Total Medicare services vs. 101 Sleep Medicine providers in CA — top quintile (cohort median 473).

PRESCRIBING · PART D · 2024

Total Rx claims

3,329

Beneficiaries

—

Total drug cost

$181K

Distinct drugs

Brand share

16.8%

Top prescribed drugs

Atorvastatin Calcium258 claims

Levothyroxine Sodium210 claims

Amlodipine Besylate189 claims

Losartan Potassium178 claims

Lisinopril162 claims

QUALITY · MIPS · 2024

Final MIPS score

91.7

Quality

100.0

Cost

70.4

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.70%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050380

Hospital

REFERRAL NETWORK

Where Sudha Karupaiah's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
GOOD SAMARITAN HOSPITAL, L.P.	11	15

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · San Jose, CA	38	133
O'CONNOR HOSPITAL	23	61
Laboratory Corporation Of America Clinical Laboratory · San Diego, CA	23	47

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history